127 related articles for article (PubMed ID: 24755307)
1. Animals with a schizophrenia-like phenotype are differentially sensitive to the motivational effects of cannabinoid agonists in conditioned place preference.
Gallo A; Bouchard C; Rompré PP
Behav Brain Res; 2014 Jul; 268():202-12. PubMed ID: 24755307
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: a brain stimulation reward study.
Gallo A; Bouchard C; Fortier E; Ducrot C; Rompré PP
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1534-45. PubMed ID: 25092427
[TBL] [Abstract][Full Text] [Related]
3. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Gomes FV; Guimarães FS; Grace AA
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
[TBL] [Abstract][Full Text] [Related]
4. Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure.
Polissidis A; Chouliara O; Galanopoulos A; Marselos M; Papadopoulou-Daifoti Z; Antoniou K
Life Sci; 2009 Jul; 85(5-6):248-54. PubMed ID: 19508876
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat-an animal model of attention deficit hyperactivity disorder.
Pandolfo P; Vendruscolo LF; Sordi R; Takahashi RN
Psychopharmacology (Berl); 2009 Aug; 205(2):319-26. PubMed ID: 19407992
[TBL] [Abstract][Full Text] [Related]
6. Effects of delta9-THC and WIN-55,212-2 on place preference in the water maze in rats.
Robinson L; Hinder L; Pertwee RG; Riedel G
Psychopharmacology (Berl); 2003 Feb; 166(1):40-50. PubMed ID: 12488948
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression.
Segev A; Rubin AS; Abush H; Richter-Levin G; Akirav I
Neuropsychopharmacology; 2014 Mar; 39(4):919-33. PubMed ID: 24141570
[TBL] [Abstract][Full Text] [Related]
8. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats.
Drews E; Schneider M; Koch M
Pharmacol Biochem Behav; 2005 Jan; 80(1):145-50. PubMed ID: 15652390
[TBL] [Abstract][Full Text] [Related]
9. Memantine Prevents the WIN 55,212-2 Evoked Cross-Priming of Ethanol-Induced Conditioned Place Preference (CPP).
Marszalek-Grabska M; Smaga I; Surowka P; Grochecki P; Slowik T; Filip M; Kotlinska JH
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360704
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.
López-Moreno JA; González-Cuevas G; Rodríguez de Fonseca F; Navarro M
J Neurosci; 2004 Sep; 24(38):8245-52. PubMed ID: 15385608
[TBL] [Abstract][Full Text] [Related]
11. Repeated administration of a synthetic cannabinoid receptor agonist differentially affects cortical and accumbal neuronal morphology in adolescent and adult rats.
Carvalho AF; Reyes BA; Ramalhosa F; Sousa N; Van Bockstaele EJ
Brain Struct Funct; 2016 Jan; 221(1):407-19. PubMed ID: 25348266
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
13. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
14. Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference.
Hashemizadeh S; Sardari M; Rezayof A
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():65-71. PubMed ID: 24468643
[TBL] [Abstract][Full Text] [Related]
15. Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner.
Galanopoulos A; Polissidis A; Papadopoulou-Daifoti Z; Nomikos GG; Antoniou K
Behav Brain Res; 2011 Oct; 224(1):65-72. PubMed ID: 21645556
[TBL] [Abstract][Full Text] [Related]
16. Link between personality and response to THC exposure.
Kardash T; Rodin D; Kirby M; Davis N; Koman I; Gorelick J; Michaelevski I; Pinhasov A
Behav Brain Res; 2020 Feb; 379():112361. PubMed ID: 31734264
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
Li M; He W; Mead A
Behav Pharmacol; 2009 Feb; 20(1):84-98. PubMed ID: 19179852
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats.
Spano MS; Fadda P; Frau R; Fattore L; Fratta W
Eur Neuropsychopharmacol; 2010 Jan; 20(1):25-36. PubMed ID: 19854030
[TBL] [Abstract][Full Text] [Related]
19. Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats.
Shiri M; Komaki A; Oryan S; Taheri M; Komaki H; Etaee F
Can J Physiol Pharmacol; 2017 Apr; 95(4):382-387. PubMed ID: 28112976
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
